Partnership Opportunities

Hanson wade have taken the decision to cancel this meeting. Please do accept our apologies for any inconvenience or disappointment this will cause.

Durability is a priority for any gene therapy company looking to deliver a commercially successful product. This provides a special opportunity for animal model providers and assay developers/providers to establish themselves as the leading commercial partners for the companies who are spearheading this innovation.

Partner with the Gene Therapy Durability Summit to influence the rapidly growing landscape and showcase your company as the go-to for solving durability-related challenges.

Don’t miss out on the opportunity to forge new collaborations with 100+ biotech and pharma leaders who will unite in April at the Gene Therapy Durability Summit.

Email sponsor@hansonwade.com for more information on the partnership opportunities we offer, bespoke and tailorable to your business goals for hitting commercial objectives for 2023 and beyond.

Experts Need Your Help With:

https://genetherapy-durability.com/wp-content/uploads/sites/843/2022/12/cropped-Favicon.png

Rodent, canine or other large animal models

https://genetherapy-durability.com/wp-content/uploads/sites/843/2022/12/cropped-Favicon.png

Non-human primate models for preclinical studies

https://genetherapy-durability.com/wp-content/uploads/sites/843/2022/12/cropped-Favicon.png

Imaging, digital and blood-based biomarker expertize

https://genetherapy-durability.com/wp-content/uploads/sites/843/2022/12/cropped-Favicon.png

Assays for reliable immunogenicity testing

Why Partner?

2
3
1

Demonstrate your expert knowledge by securing an exhibition booth

Showcase your pioneering solutions and drive brand awareness with a spot on our expert speaker faculty

Maximize networking opportunities to forge new relationships with industry leaders

Who Will You Meet?

Engage an audience of leading pharma and biotech organizations Graph